What does CUSIP 14888U101 represent in this 13F holders report?

CUSIP 14888U101 is the security identifier for CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in Q3 2019?

117 institutional investors reported CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock for Q3 2019. Use the holders table for investor-level position and value details.

CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q3 2019 13F Holders as of 30 Sep 2019

Security type / class: Equity / Common Stock
Shares outstanding: 123,180,519
Total 13F shares: 61,617,508
Share change: +59,183
Total reported value: $327,170,529
Put/Call ratio: 350%
Reported price per share: $5.31
Number of holders: 117
Value change: +$8,126,558
Number of buys: 69
Number of sells: 40

Security key

14888U101

Report period

Q3 2019

Institutions

117

Top holders

CPRX full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2019 Previous quarter: Q2 2019 CATALYST PHARMACEUTICALS, INC. SEC filings CATALYST PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 14888U101

Newer quarter: Q4 2019 Previous quarter: Q2 2019

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Consonance Capital Manage...

13D/G signal

—

Evidence rows

Latest as of

30 Jun 2019

13F Lead comparable stake: 15% Showing 1-6 of 15 holder rows.

Rank 1 holder

Consonance Capital Management LP

13F

Ownership: 15%
Position: $68.64M

13F

Rank 2 holder

BlackRock Finance, Inc.

13F

Ownership: 6.6%
Position: $31.02M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Consonance Capital Management LP	13F Company 13F	15%	$68,643,000 17,875,655 shares	—	30 Jun 2019
BlackRock Finance, Inc.	13F Company 13F	6.6%	$31,023,000 8,078,995 shares	—	30 Jun 2019
ARMISTICE CAPITAL, LLC	13F Company 13F	4.1%	$19,200,000 5,000,000 shares	—	30 Jun 2019
VANGUARD GROUP INC	13F Company 13F	3.9%	$18,669,000 4,861,728 shares	—	30 Jun 2019
MANGROVE PARTNERS IM, LLC	13F Company 13F	3.1%	$14,735,000 3,837,181 shares	—	30 Jun 2019
Broadfin Capital, LLC	13F Company 13F	2.2%	$10,618,000 2,765,070 shares	—	30 Jun 2019

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

117

61,617,508

Rows available

117

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders

Q3 2019 holders

117

Holder diff

Investor	Q2 2019 Shares	Q3 2019 Shares	Share Diff	Share Chg %	Q2 2019 value	Q3 2019 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend